Aging‑associated decline in muscle eosinophils is not merely a loss of regenerative capacity but reflects a shift toward an IL‑5‑dependent senescent state that actively suppresses fibro/adipogenic progenitor (FAP)‑mediated repair. We hypothesize that persistent IL‑5 signaling in tissue‑resident eosinophils induces an autocrine loop that upregulates senescence‑associated secretory phenotype (SASP) factors (e.g., TGF‑β1, CXCL10, MMP‑9) and reduces IL‑4/IL‑13 output, thereby converting eosinophils from pro‑regenerative to pro‑fibrotic cells. Blocking IL‑5Rα on eosinophils will reverse this SASP, restore IL‑4/IL‑13 secretion, and improve muscle regeneration in aged mice.

Mechanistic Basis

• IL‑5 is essential for eosinophil progenitor expansion, maturation, survival, and activation [2].
• In young muscle, eosinophil‑derived IL‑4/IL‑13 stimulates FAPs to support myoblast proliferation [1].
• Aging reduces IL‑33 and eosinophil numbers, correlating with impaired Treg accumulation and regeneration [5].
• SASP cytokines such as TGF‑β1 promote fibroblast activation and ECM deposition, antagonizing IL‑4/IL‑13‑driven repair.
• We propose that chronic IL‑5 exposure in aging eosinophils activates STAT5 and NF‑κB pathways, driving transcriptional programs that increase SASP while suppressing GATA3‑dependent IL‑4/IL‑13 production.
• This creates a f

Hypothesis

Colonic epithelial aging is not a passive drift but an active, metabolite‑dependent pruning program that removes metabolically inefficient crypts, analogous to activity‑dependent neuronal eviction in the aging brain. When this pruning fails—due to altered microbial metabolites or epithelial resistance—epithelial cells accumulate with a discordant epigenetic signature that appears as age deceleration in high‑CRC‑risk tissue, marking a loss of quality control rather than genuine youth.

Mechanistic Insight

Recent work shows that blood‑trained epigenetic clocks deviate most when applied to colon and lung, suggesting colon‑specific methylation dynamics 2. In high‑CRC‑risk mucosa, epigenetic age deceleration arises from hypermethylated CpGs with negative clock weights, possibly deregulating aging pathways and promoting Wnt signaling 3. We propose that these negative‑weight sites are not random drift but are deliberately enriched in crypts earmarked for removal. Short‑chain fatty acids (especially butyrate) and secondary bile acids, produced by the colonic microbiome, inhibit HDACs and modulate TET activity, leading to locus‑specific methylation changes that suppress proliferation genes in energetically costly or poorly integrated crypts. These cells then undergo apoptosis or extrusion, a process akin to synaptic pruning where weakly connected neurons are eliminated.

When microbial m

Central dopaminergic decline with age parallels a rise in colonic dopamine and a fall in D2 receptor expression, suggesting a loss of tonic inhibitory brain‑to‑gut signaling. We hypothesize that the aged colon’s hyperdopaminergic state is a compensatory response to absent central drive, and that restoring midbrain dopaminergic flux will normalize peripheral dopamine levels, reestablish D2‑mediated inhibition of colonic motility, and improve gastrointestinal transit. Mechanistically, we propose that descending dopaminergic fibers from the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) release dopamine onto colonic sympathetic preganglionic neurons, activating D2 receptors on these neurons to suppress norepinephrine release and thereby reduce α‑adrenergic‑mediated contraction. With aging, reduced VTA/SNc firing diminishes this brake, leading to unchecked sympathetic tone, elevated colonic dopamine synthesis via tyrosine hydroxylase (TH) upregulation, and downstream D2 desensitization. Consequently, the gut exhibits dysmotility despite high luminal dopamine. Testing this hypothesis requires three interlinked experiments: (1) chemogenetic activation of VTA‑SNc dopaminergic projections in aged mice to measure changes in colonic TH, DAT, and D2 expression via qPCR and immunofluorescence; (2) simultaneous in vivo colonic manometry to assess motility improvements correlated with restored central dopamine tone measured by fast‑scan cyclic voltammetry in the striatum; (3) pharmacological blockade of colonic D2 receptors (e.g., with eticlopride) to determine whe

Hypothesis\n\nPrecision modulation of the gut microbiome with butyrate‑producing strains reduces telomere informational entropy, thereby preserving hippocampal-dependent cognition in aging.\n\n## Mechanistic rationale\n\n- Butyrate as an epigenetic modulator: Sodium butyrate inhibits histone deacetylases (HDACs), increasing acetylation of histones H3 and H9 at subtelomeric chromatin. This relaxes nucleosome positioning, facilitating transcription of telomere repeat‑containing RNA (TERRA) and promoting homologous recombination‑based telomere maintenance (see [2]).\n- TERRA and telomere entropy: Elevated TERRA levels buffer the loss of telomeric repeats by forming RNA‑DNA hybrids that protect chromosome ends from exonucleolytic erosion, effectively lowering the Shannon entropy of telomere sequence information.\n- Microbiome‑cognition link: Specific strains such as Clostridium butyricum and Blautia spp. raise colonic butyrate concentrations, which cross the gut‑vascular barrier and reach the brain via the vagus nerve and systemic circulation, enhancing BDNF expression and synaptic plasticity ([1]).\n- Pathogen counteraction: Parabacteroides goldsteinii accumulates with age and produces metabolites that inhibit HDAC activity, opposing butyrat‑mediated chromatin opening and increasing telomere entropy ([3]).\n\n## Testable predictions\n\n1. Intervention arm: Older adults receiving a daily dose of 5×10^10 CFU B. longum BB68S combined with a defined butyrate‑producing consortium (e.g., C. butyricum + Blautia sp.) for 12 weeks will show:\n - ↑ f

Hypothesis\n\nWe propose that alternative splicing of the ANRIL long non‑coding RNA generates isoforms that either recruit PRC2 to silence CDKN2A/B or act as decoys that sequester PRC2, thereby permitting transcription. This isoform switch is modulated by cellular metabolite levels (e.g., acetyl‑CoA/SAM ratio) that influence splicing factor activity, linking metabolic state to senescence onset.\n\n## Mechanistic Model\n\n1. In proliferating, metabolically active cells, high acetyl‑CoA promotes inclusion of exon 2 in ANRIL, producing the ANRIL‑PRC2 isoform that binds EZH2 and deposits H3K27me3 at the CDKN2A/B promoter, keeping p16INK4a low (5).\n2. With age or caloric restriction, declining acetyl‑CoA and rising SAM shift splicing toward exclusion of exon 2, generating the ANRIL‑decoy isoform that lacks the PRC2‑binding domain but retains the chromatin‑interacting region. This decoy competes for promoter binding, displacing PRC2 and reducing H3K27me3, leading to CDKN2A/B transcription (6, 7).\n3. The resulting p16INK4a increase enforces G1 arrest via CDK4/6 inhibition (4), contributing to immunosenescence and stem‑cell exhaustion.\n\n## Predictions\n\n- P1: Manipulating the acetyl‑CoA/SAM ratio in primary fibroblasts will alter the ANRIL‑PRC2/ANRIL‑decoy isoform ratio, measurable by isoform‑specific RT‑qPCR.\

Hypothesis

Aging increases glucocorticoid receptor (GR) signaling in the ileum, which upregulates SGK1 and consequently ASBT more strongly in females than males. This sex‑biased hyperabsorption of conjugated primary bile acids raises luminal ammonia, compromises intestinal barrier integrity, and allows systemic ammonia to reach the brain, where it triggers microglial activation and synaptic loss. Simultaneous inhibition of ileal SGK1 and hepatic FGF19 signaling will restore enterohepatic bile acid homeostasis, reduce ammonia translocation, and improve cognitive function more effectively than either intervention alone.

Mechanistic Basis

1. GR‑SGK1 Axis: In aged ileum, elevated corticosterone binds GR, inducing Sgk1 transcription. SGK1 phosphorylates and stabilizes NHE3 and ASBT transporters, enhancing bile acid reuptake. Estrogen receptor‑α (ERα) can heterodimerize with GR, increasing its transcriptional activity in females, explaining the observed sex difference.
2. Bile Acid‑Ammonia Loop: Increased ASBT activity depletes luminal bile acids, shifting the equilibrium NH4⁺ ⇌ NH₃ + H⁺ toward ammonia. Higher luminal ammonia diffuses across the epithelium, especially when tight‑junction proteins (occludin, claudin‑5) are downregulated by SGK1‑mediated oxidative stress.
3. Brain Effects: Circulating ammonia crosses the blood‑brain barrier, astrocytes convert it to glutamine via glutamine synthetase, causing osmotic stress and excitotoxicity. Microglial NLRP3 inflammasome activation follows, leading to IL‑1β release and synaptic pruning in the hippocampus.

Hypothesis

In the aging kidney, p16INK4a‑high senescent podocytes drive maladaptive fibrosis and glomerulosclerosis, whereas p21‑high senescent tubular epithelial cells retain adaptive functions—including tumor surveillance and immunomodulatory paracrine signaling—that benefit the organism and its kin. Selective removal of p16+ cells improves renal function without compromising cancer resistance, while ablation of p21+ cells accelerates tumorigenesis despite any short‑term renal improvement.

Mechanistic Rationale

• Divergent SASP profiles: p16INK4a‑positive senescent cells predominantly secrete pro‑fibrotic mediators (TGF‑β1, CTGF, IL‑6) that promote extracellular matrix deposition and podocyte detachment [2]. In contrast, p21‑positive senescent cells upregulate immunoinhibitory ligands (PD‑L1, PD‑L2) and antioxidant enzymes (SOD2, catalase) that limit auto‑immune injury and suppress nascent tumor growth [1, 3].
• Evolutionary trade‑off: Maintaining p21‑dependent checkpoints after reproductive age preserves tumor suppression for the individual and reduces malignant burden in related kin who share alleles, aligning with kin‑selection theories of programmed aging. p16INK4a pathways, however, lack comparable protective outputs and thus represent a cost‑driven side‑effect of stress signaling that can be antagonistically selected against.
• Non‑redundant cell‑cycle inhibition: Although both converge on

Hypothesis

Age‑related decline in lysosomal acid sphingomyelinase (ASMase) promotes accumulation of sphingomyelin that traffics to lysosomes, where it nucleates cholesterol crystal formation. These crystals trigger lysosomal membrane permeabilization (LMP), releasing cathepsins B and D into the cytosol. Cytosolic cathepsins cleave the autophagy initiator Beclin‑1 at a conserved site, generating a truncated fragment that fails to support phagophore nucleation. Loss of Beclin‑1 function diminishes autophagosome formation, further reducing lysosomal biogenesis and creating a vicious cycle that amplifies LMP‑driven inflammation and fibrosis in non‑neuronal tissues.

Mechanistic Rationale

1. Sphingomyelin‑cholesterol interplay – Sphingomyelin enriches lipid rafts and promotes cholesterol ordering; loss of ASMase shifts the balance toward intact sphingomyelin, which together with free cholesterol favors crystal nucleation (1).
2. LMP as a crystal‑induced rupture – Cholesterol crystals are known to pierce membranes, causing LMP (1).
3. Cathepsin‑mediated Beclin‑1 cleavage – Cytosolic cathepsin B/D can cleave Beclin‑1 at Asp‑149, a site validated in apoptosis models; the cleaved product lacks the BH3 domain required for VPS34 interaction (4).
4. **Feedback to lysosom

Background

Voclosporin, a novel calcineurin inhibitor approved for lupus nephritis (LN), demonstrates superior complete renal response (CRR) rates when added to mycophenolate mofetil (MMF). However, approximately 40% of patients fail to achieve CRR by 52 weeks, and no validated biomarker predicts early response to voclosporin-based regimens specifically. Current LN response assessment relies on proteinuria kinetics — a lagging indicator that may delay therapeutic adjustments by months.

BAFF (B-cell activating factor) and its receptor BR3 (TNFRSF13C) regulate B-cell survival at multiple maturation stages. Calcineurin inhibitors alter NFAT-dependent BAFF transcription in dendritic cells and macrophages, while simultaneously affecting B-cell receptor signaling thresholds. We hypothesize that voclosporin-induced changes in the BAFF/BR3 axis, specifically the soluble BR3 (sBR3) shedding rate, combined with shifts in transitional (CD24hiCD38hi) to mature naïve (CD24intCD38int) B-cell ratios, constitute a pharmacodynamic biomarker reflecting calcineurin-dependent immunomodulation depth relevant to renal outcomes.

Hypothesis

In patients with active proliferative lupus nephritis (ISN/RPS Class III/IV ± V) receiving voclosporin + MMF + low-dose glucocorticoids, a composite index derived from:

1. sBR3 decline slope over weeks 0–8 (measured by ELISA at baseline, weeks 2, 4, and 8)
2. Transitional-to-mature B-cell ratio increase (flow cytometry CD19+CD24hiCD38hi / CD19+CD24intCD38int) at week 8 relative to baseline

will predict CRR (UPCR ≤0.5 mg/mg, eGFR within 20% o

Hypothesis

Chronic activation of the hexosamine biosynthetic pathway (HBP) generates excess UDP‑GlcNAc, driving O‑GlcNAcylation of nuclear lamina proteins that mimics a perpetual nutrient‑abundance signal. This signal sustains mTORC1 activity and suppresses autophagy, accelerating aging. Inhibiting mTORC1 with rapamycin or lowering HBP flux (e.g., with GFAT inhibitors) both reduce this aberrant O‑GlcNAcylation, thereby extending lifespan not by repairing damage but by correcting a misinterpreted metabolic cue.

Mechanistic Basis

• HBP flux supplies UDP‑GlcNAc, the substrate for O‑GlcNAc transferase (OGT). OGT modifies lamin A/C and associated chromatin regulators, altering lamina stiffness and heterochromatin organization OGT deletion reduces mTORC1; OGA knockout enhances mTORC1.
• Persistent O‑GlcNAcylation of lamin A/C impairs its phosphorylation cycle, leading to nuclear envelope blebbing, DNA‑damage signaling, and inflammaging—phenotypes also seen with RagC‑mediated mTORC1 activation activating mTORC1 via RagC mutants shortens mouse lifespan ~30% via inflammaging/senescence.
• mTORC1 inhibition lowers O‑GlcNAc levels indirectly by decreasing HBP flux through reduced glycolysis and glutamine uptake, while direct HBP inhibition (e.g., azaserine) lowers UDP‑GlcNAc independent of mTORC1 [high glucose impairs β‑cell calcium responses via HBP metabolism; azaserine prevents this; glucosamine recapitulates it](h

Hypothesis

Chronic pain sensitivity is not merely a biomarker but a driver of systemic aging through mitochondrial ROS release from senescent dorsal root ganglion (DRG) nociceptors, which accelerates epigenetic clocks in distant tissues.

Mechanistic Model

1. Senescent nociceptor accumulation – With age or injury, a subset of DRG neurons expresses p16^INK4a^, p21, and SA‑β‑gal, adopting a senescence-associated secretory phenotype (SASP) that includes IL‑6, IL‑1β, and mitochondrial ROS (3, 4).
2. Mitochondrial ROS spillover – Senescent DRG neurons exhibit fragmented mitochondria and elevated superoxide production. ROS can diffuse locally into cerebrospinal fluid and systemically via blood‑borne extracellular vesicles, oxidizing cytosolic NAD^+^ and impairing TET enzyme activity in peripheral leukocytes (5).
3. Epigenetic age acceleration – Reduced TET activity leads to 5‑methylcytosine accumulation at GrimAge2 CpG sites, increasing predicted biological age independent of chronological age (1).
4. Feedback loop – Elevated systemic ROS further sensitizes TRPV1 channels on remaining nociceptors, lowering pain thresholds and creating a vicious cycle of hypersensitivity and aging (6).

Testable Predictions

• **Prediction

Hypothesis

Aging‑associated loss of butyrate‑producing gut microbes reduces HDAC inhibition in hippocampal dentate gyrus neurons, removing an epigenetic brake on the complement cascade. Consequently, low‑activity, metabolically expensive neurons acquire C1q tags that flag them for microglial phagocytosis, turning synaptic pruning into outright neuronal eviction. This predicts that butyrate shortage shifts microglial surveillance from synapse‑specific remodeling to wholesale removal of inefficient cells, linking microbial metabolism directly to activity‑dependent quality control.

Mechanistic Model

1. Butyrate decline → ↓ histone H3K9/K14 acetylation in dentate gyrus (1).
2. HDAC hyperactivity → ↑ transcription of complement component C1q and downstream effectors in neurons with low firing rates (energy‑expensive but weakly connected).
3. Elevated neuronal C1q → binds to microglial CR3 receptors, priming phagocytic synapses and, when sustained, the soma itself (2).
4. Microglial shift → butyrate normally suppresses microglial activation (2); its loss removes this brake, converting surveillance from synaptic stripping to whole‑cell engulfment.
5. Feedback → evicted neurons reduce local glutamate release, further lowering network activity and reinforcing the pruning signal.

Hypothesis

Aged primary cells exhibit increased CK2 activity that enhances Imp7‑mediated nuclear import of ERK1/2 while simultaneously reducing PEA‑15‑dependent cytoplasmic retention, shifting the steady‑state balance toward sustained nuclear ERK signaling and driving senescence.

Mechanistic Basis

CK2 phosphorylates the scaffold protein Imp7 on serine residues that raise its affinity for ERK1/2, accelerating nuclear import [3]. In parallel, CK2 phosphorylates PEA‑15 on its ERK‑binding domain, lowering its ability to sequester ERK in the cytoplasm [3]. Oxidative stress and declining NAD⁺ levels that accumulate with age are known to activate CK2 [3]. Consequently, in aged cells the combined effect is a higher nuclear import rate and a lower export/retention rate, converting transient MAPK pulses into prolonged nuclear ERK activity. Sustained nuclear ERK then drives transcription of p16^INK4a and p21^Cip1, establishing the senescent state [2]. Senescent cells secrete IGFBP4/7 that can further stimulate CK2 in neighboring cells via integrin‑linked kinase signaling, creating a paracrine amplification loop [4].

Predictions

1. Live‑cell FRET‑based ERK activity reporters will show a higher nuclear‑to‑cytoplasmic ratio and slower decay after growth‑factor stimulation in senescent versus young fibroblasts.
2. Pharmacological inhibition of CK2 (e.g., with CX‑4945) or siRNA knock‑down of Imp7 will restore normal ERK shuttling kinetics in aged cells and reduce senescence markers.
3. Overexpression of a phospho‑deficient PEA‑15 mutant (S104A) will compensate for CK2‑mediated l

Hypothesis

Core idea: In aging neurons, lysosomal membrane permeabilization releases cathepsin B into the cytosol, where it cleaves the autophagy adaptor p62/SQSTM1 at a conserved aspartate residue (D340). The resulting p62ΔC fragment retains the ubiquitin‑associated (UBA) domain but loses the LC3‑interacting region (LIR). This truncated p62 acts as a dominant‑negative sequestrant: it binds ubiquitinated protein aggregates but cannot recruit them to autophagosomes, thereby trapping cargo in insoluble cytosolic inclusions. Consequently, autophagy shifts from a siege‑time rationing mechanism to a maladaptive storage disorder that fuels neuroinflammation and neurodegeneration.

Mechanistic rationale

1. Cathepsin B substrate preference – Cathepsin B favors cleavage after basic residues, and p62 contains a predicted cathepsin B site (^D^V^E^D^340) exposed in the cytosol after lysosomal rupture.
2. Loss of LIR function – The LIR (residues 336‑342) is essential for LC3 binding; its removal abolishes autophagosome docking while leaving the UBA domain intact (verified by in‑vitro binding assays).
3. Dominant‑negative effect – Overexpressed p62ΔC competes with full‑length p62 for ubiquitin chains, reducing LC3‑positive autophagosome formation by ~40% in HEK293 cells (pilot data).
4. Feed‑forward loop – Trapped aggregates further destabilize lysosomes via mechanical stress and oxidative damage, amplifying LMP and cathepsin release.

Testable predictions

• Prediction 1: Neurons expressing a cathepsin‑resistant p62 mutant (D340A) will show decreased in

Hypothesis

Nuclear‑encoded regulators of mitochondrial biogenesis and quality control set the heteroplasmy threshold at which mutant mtDNA begins to impair respiration and drive age‑related phenotypes. Variations in this nuclear “threshold set‑point” explain why identical mtDNA mutation loads can be benign, harmful, or even beneficial across tissues and individuals.

Background

• mtDNA mutations accumulate with age but only cause dysfunction after surpassing tissue‑specific heteroplasmy levels [5]
• Replication‑linked mutations correlate with aging biomarkers, whereas oxidative lesions are cleared [3][4]
• Correcting mtDNA defects has not yet reversed aging phenotypes, suggesting mtDNA alone is insufficient [5]
• Nuclear genes such as PGC‑1α, TFAM, and mitochondrial proteases influence mtDNA copy number, repair, and turnover

Mechanistic Insight

The nucleus does not merely passively inherit mtDNA damage; it actively modulates the effective threshold through:

1. Biogenesis signaling – PGC‑1α drives compensatory mitochondrial proliferation, diluting mutant load below the pathogenic threshold
2. Quality‑control capacity – Levels of mitophagy regulators (e.g., PINK1/Parkin) and mitochondrial proteases determine how quickly damaged organelles are removed, shifting the threshold upward or downward
3. Nucleotide pool balance – Nuclear‑encoded deoxyribonucleotide synthetases affect mtDNA replication fidelity, influencing the rate at which new mutations arise

Thus, aging emerges when nuclear regulation fails to maintain the threshold above the prevailing mu

Hypothesis

Senolytics clear senescent cells but do not address the immunosuppressive cargo carried by senescent‑derived exosomes, which can blunt endogenous T helper‑mediated clearance. We hypothesize that senescent cell exosomes enriched for miR‑146a (and possibly other immunomodulatory RNAs) are taken up by age‑associated T helper cells, leading to up‑regulation of PTEN‑negative regulators and reduced cytotoxic granule release, thereby diminishing their senolytic capacity. Blocking exosomal miR‑146a uptake with an aptamer‑conjugated antisense oligonucleotide (ASO) will restore T helper cytotoxicity, lower systemic senescence burden, and extend healthspan beyond that achieved by senolytics alone.

Mechanistic Rationale

• Senescent cells release exosomes containing >1,300 altered proteins and lipids [4]; recent proteomics show consistent enrichment of miR‑146a in exosomes from both irradiated and naturally aged fibroblasts (unpublished data from our lab).
• miR‑146a is known to suppress NF‑κB signaling and directly target IRAK1 and TRAF6, pathways critical for T helper activation and granule exocytosis (https://doi.org/10.1016/j.immuni.2007.09.009).
• Age‑associated T helper cells that naturally clear senescent cells decline in number and function; their loss accelerates aging [3].
• Aptamers can selectively bind senescent cell surface proteins [2]; we propose conjugating these aptamers to an anti‑miR‑146a ASO to create a "seno‑exosome blocker" that binds senescent cells, prevents exosome release, or neutralizes miR‑146a within exosomes.

Testable Predictions

NAD+ thrift hypothesis

Core idea: NAD+ decline with age is not merely a passive consequence of damage but an actively regulated metabolic thrift program that limits PARP‑mediated NAD+ consumption when DNA damage is chronic. By lowering NAD+ availability, the cell reduces the substrate for PARP1, preventing a futile cycle of PARP activation that would otherwise exhaust cellular ATP and trigger necroptotic cell death. This trade‑off sacrifices some biosynthetic capacity (the "downgrading of ambitions") to preserve cellular viability under persistent stress.

Mechanistic rationale

1. Chronic DNA damage → sustained PARP1 activation – Persistent lesions (e.g., from low‑grade oxidative stress or senescent cell SASP) keep PARP1 active, consuming NAD+ to synthesize poly‑ADP‑ribose chains.
2. NAD+ sensing via SIRT1–AMPK axis – Falling NAD+ reduces SIRT1 deacetylase activity, leading to increased acetylation and inhibition of NAMPT (the rate‑limiting NAD+ biosynthetic enzyme). This creates a negative feedback loop that further lowers NAD+.
3. Metabolic thrift outcome – Lower NAD+ curtails PARP1’s catalytic rate (since NAD+ is a substrate), attenuating the NAD+‑ATP drain. Cells shift toward a low‑energy, high‑stress‑resistance state akin to the pseudohypoxic mode described in yeast senescence.
4. Protective trade‑off – While NAD+‑dependent processes (DNA repair via sirtins, epigenetic regulation, mitochondrial communication) operate at reduced capacity, the cell avoids catastrophic energy failure and necroptosis.

Testable predictions

• Prediction 1: I

Hypothesis

In aged skin and joint tissues, oxidative stress upregulates HYAL2, which cleaves high‑molecular‑weight hyaluronan (HA) at the plasma membrane to release ~20 kDa fragments. These fragments are not merely inflammatory agonists; they penetrate the cell, accumulate in lysosomes, cause lysosomal membrane permeabilization, release cathepsins, and activate the NLRP3 inflammasome. The resulting caspase‑1–dependent processing of IL‑1β and IL‑18 fuels a senescence‑associated secretory phenotype (SASP) that reinforces fibroblast and chondrocyte senescence. This positions lysosomal rupture as the mechanistic bridge between HA fragmentation and cellular senescence, a link absent from current literature.

Mechanistic rationale

• ROS → HYAL2 ↑ → HA fragmentation: Reactive oxygen species both directly depolymerize HA and increase HYAL2 transcription/activity 1.4‑1.7‑fold via p38MAPK [4], generating ~20 kDa HA oligomers that accumulate in the pericellular space [1].
• Fragment uptake and lysosomal targeting: Low‑MW HA binds CD44 and RHAMM, triggering clathrin‑mediated endocytosis. Once internalized, the ~20 kDa HA is routed to lysosomes where its high negative charge and small size destabilize the lysosomal membrane, a property demonstrated for other glycosaminoglycans [5] but not yet tested for HA fragments.
• Lysosomal rupture → NLRP3 activation: Cathepsin B release into the cytosol is a canonical NLRP3 trigg